• Product NameFX1
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityFX1 is a potent and specific BCL6 inhibitor, with an IC50 of around 35 μM.
• Target NameBCL inhibitor
• CAS No. 1426138-42-2
• Calculated MW 368.806
• Formulation C14H9ClN2O4S2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:C1=CC2=C(C=C1Cl)/C(=C/3\C(=O)N(C(=S)S3)CCC(=O)O)/C(=O)N2
  Pathways:Apoptosis
  Receptor:BCL-6
  Boling pt:
  Melting pt:
  Solubility:30 mg/mL in DMSO (Need ultrasonic)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Mariano G et al. Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep 1; 126(9): 3351C3362.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting